Merck’s Ebola Vaccine Ervebo Prequalified by WHO

Bookmark
(Bloomberg) -- The World Health Organization prequalified an ebola vaccine for the first time -- Merck’s vaccine, Ervebo -- which speeds up licensing, access and roll-out in high-risk countries.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.